Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder associated with loss of striatal dopamine, secondary to degeneration of midbrain dopamine (mDA) neurons in the substantia nigra, rendering cell transplantation a promising therapeutic strategy. To establish human induced pluripotent stem cell-based (hiPSC-based) autologous cell therapy, we report a platform of core techniques for the production of mDA progenitors as a safe and effective therapeutic product. First, by combining metabolism-regulating microRNAs with reprogramming factors, we developed a method to more efficiently generate clinical-grade iPSCs, as evidenced by genomic integrity and unbiased pluripotent potential. Second, we established a "spotting"-based in vitro differentiation methodology to generate functional and healthy mDA cells in a scalable manner. Third, we developed a chemical method that safely eliminates undifferentiated cells from the final product. Dopaminergic cells thus express high levels of characteristic mDA markers, produce and secrete dopamine, and exhibit electrophysiological features typical of mDA cells. Transplantation of these cells into rodent models of PD robustly restores motor function and reinnervates host brain, while showing no evidence of tumor formation or redistribution of the implanted cells. We propose that this platform is suitable for the successful implementation of human personalized autologous cell therapy for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Yamanaka’s and two other groups subsequently accomplished this feat with human somatic cells, reprograming them into human iPSCs (hiPSCs) (9-11), offering the possibility of generating patient-specific stem cells.”
BackgroundMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · cited 4×
“evidenced by (1) staining with antibodies against the three germ layer markers and (2) gene expression of lineage-specific markers (Figure 2, C and D).”
BackgroundInfluentialHighly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620 · cited 1×
“Since the embryoid body–derived neurosphere-based method is highly variable between experiments (18, 35, 36), we sought to establish more efficient and reproducible monolayer methods based on dual-SMAD inhibition (36, 37).”
MethodSomatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396 · cited 1×
“We estimated the distribution of allelic fractions in observed somatic mutations and performed binomial tests with a null model of 45% as the center for single nucleotide variants (SNVs) and 35% as the center for indels (28, 30).”
MethodHuman iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
Kikuchi, T., Morizane, A., Doi, D., Magotani, H., Onoe, H., Hayashi, T., Mizuma, H., Takara, S., Takahashi, R., Inoue, H., et al. (2017) · Nature · doi:10.1038/nature23664 · Cited by 702 · cited 1×
“elegantly showed that hiPSC-derived DA cells can survive and ameliorate motor behaviors in MPTP-lesioned monkey models (65), but direct comparison of those results with our study is hindered by the different species platform used.”
ResultCommon genetic variation drives molecular heterogeneity in human iPSCs
Kilpinen, H., Goncalves, A., Leha, A., Afzal, V., Alasoo, K., Ashford, S., Bala, S., Bensaddek, D., Casale, F. P., Culley, O. J., et al. (2017) · Nature · doi:10.1038/nature22403 · Cited by 586 · cited 1×
“We collected high-confidence somatic mutations from WES based on 140 hESC lines (28) and somatic coding mutations from WGS data for 299 hiPSC lines (generated by Sendai virus method) in the Human Induced Pluripotent Stem Cells Initiative (HipSci) (29).”
MethodHuman pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. (2017) · Nature · doi:10.1038/nature22312 · Cited by 506
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460
Cited by
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
Schweitzer, J. S., Song, B., Herrington, T. M., Park, T.-Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915872 · Cited by 542
Self-citationCo-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease
Park, T.-Y., Jeon, J., Lee, N., Kim, J., Song, B., Kim, J.-H., Lee, S.-K., Liu, D., Cha, Y., Kim, M., et al. (2023) · Nature · doi:10.1038/s41586-023-06300-4 · Cited by 128
Self-citation
Metadata
- Authors
- Song, B., Cha, Y., Ko, S., Jeon, J., Lee, N., Seo, H., Park, K.-J., Lee, I.-H., Lopes, C., Feitosa, M., Luna, M. J., Jung, J. H., Kim, J., Hwang, D., Cohen, B. M., Teicher, M. H., Leblanc, P., Carter, B. S., Kordower, J. H., Bolshakov, V. Y., Kong, S. W., Schweitzer, J. S., & Kim, K.-S.
- Venue
- Journal of Clinical Investigation
- Published
- 2020-01-13
- Volume
- 130
- Issue
- 2
- Pages
- 904-920
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2988909735
- Cited by
- 189
- References
- 15
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models. https://app.cochat.ai/papers/10.1172/jci130767
- The paper
- Song, B., Cha, Y., Ko, S., Jeon, J., Lee, N., Seo, H., Park, K.-J., Lee, I.-H., Lopes, C., Feitosa, M., Luna, M. J., Jung, J. H., Kim, J., Hwang, D., Cohen, B. M., Teicher, M. H., Leblanc, P., Carter, B. S., Kordower, J. H., . . . Kim, K.-S. (2020). Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models. Journal of Clinical Investigation. https://doi.org/10.1172/jci130767
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.